Comparison

CHIR-124 European Partner

Item no. TMO-T6350-100mg
Manufacturer TargetMol
CASRN 405168-58-3
Amount 100 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 1 mL 25 mg 2 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Citations 1. Tse AN, et al, Clin Cancer Res, 2007, 13(2 Pt 1), 591-602.
Smiles Clc1ccc2[nH]c(=O)c(-c3nc4ccccc4[nH]3)c(N[C@@H]3CN4CCC3CC4)c2c1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias CHIR124,CHIR 124
Shipping Condition Cool pack
Available
Manufacturer - Targets
Chk|||GSK-3|||FLT|||Apoptosis|||Src|||PDGFR
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
419.91
Description
CHIR-124 is an effective Chk1 inhibitor (IC50: 0.3 nM). It has 2, 000-fold selectivity against Chk2, 500- to 5, 000-fold less activity against Cdc2 and CDK2/4.
Pathways
Angiogenesis|||PI3K/Akt/mTOR signaling|||Cell Cycle/Checkpoint|||Apoptosis|||Stem Cells|||Tyrosine Kinase/Adaptors
Bioactivity
CHIR-124 is a novel and potent Chk1 inhibitor with IC50 of 0.3 nM. It shows 2, 000-fold selectivity against Chk2, 500- to 5, 000-fold less activity against CDK2/4 and Cdc2.
Receptor
Chk1; FLT3; GSK-3; PDGFR; Fyn

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close